Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 885Precursor Cell Lymphoblastic Leukemia-Lymphoma 511Hematologic Neoplasms 466Leukemia, Lymphocytic, Chronic, B-Cell 392Leukemia 337Myelodysplastic Syndromes 330Lymphoma 208Lymphoma, Non-Hodgkin 191Multiple Myeloma 146Leukemia, Myelogenous, Chronic, BCR-ABL Positive 142Recurrence 138Neoplasms 135Leukemia, Myelomonocytic, Chronic 112Burkitt Lymphoma 93Lymphoma, Mantle-Cell 92Lymphoma, Follicular 92Lymphoma, Large B-Cell, Diffuse 91Myeloproliferative Disorders 84Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 83Leukemia, Biphenotypic, Acute 81Lymphoma, B-Cell, Marginal Zone 75Hodgkin Disease 72Lymphoma, B-Cell 64Waldenstrom Macroglobulinemia 54Primary Myelofibrosis 54Leukemia, B-Cell 52Anemia, Refractory, with Excess of Blasts 46Leukemia, Myeloid, Chronic-Phase 41Hematologic Diseases 37Lymphoma, T-Cell 33

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chromosome Aberrations × Other hematologic neoplasm × 1 year × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡